F.D.A. Calls on Drug Developers to Publish Missing Data from Thousands of Trials

F.D.A. Calls on Drug Developers to Publish Missing Data from Thousands of Trials

The New York Times business

Key Points:

  • The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, medical device makers and researchers to publish clinical trial data that they

Trending Business

Trending Technology

Trending Health